Reducing the burden of diabetes will require action well beyond the health service sphere
Type 2 diabetes represents a serious public health problem for Indigenous Australians, occurring at a much higher prevalence than in the non-Indigenous population, and with a much earlier age of onset of the disease and its micro- and macrovascular complications.1,2 It is likely that diabetes is an important contributor to the considerably higher circulatory disease mortality rate among Indigenous Australians at young ages (9–10 times higher in Indigenous men aged 25–44 years, and 12–13 times higher in Indigenous women aged 35–54 years).1 Thus, diabetes imposes significant financial and human costs on Australian society, which are disproportionately borne by Indigenous individuals, families and communities.
Of three articles about diabetes in Indigenous Australians in this issue of the Journal, two provide evidence that the problem is escalating. Craig et al3 analysed data from the Australasian Paediatric Endocrine Group NSW Diabetes Register and found that type 2 diabetes accounts for 11% of new diabetes cases among 10–18-year-olds, and that the incidence in Indigenous children was about six times higher than that in non-Indigenous children (→ Type 2 diabetes in Indigenous and non-Indigenous children and adolescents in New South Wales). McDermott et al4 found that, for Torres Strait Islanders, there were significant increases in body mass index (BMI) — the major risk factor — between 1999 and 2005, and a very high 5-year incidence of diabetes (→ Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005).
Is it possible to prevent type 2 diabetes? International studies indicate that, in people with impaired glucose tolerance, an intensive focus on diet and physical activity can substantially reduce progression to diabetes, and to an equal or greater extent than pharmacological interventions.5 Although BMI and age are the two strongest predictors of diabetes for Indigenous Australians, leanness is protective.6,7 As in all Australians, preventing diabetes goes hand in hand with preventing excessive weight gain, but trends in overweight and obesity are unambiguously upwards.
Preventing excessive weight gain in Indigenous communities, which are profoundly disadvantaged relative to mainstream Australia, is complicated by the strong link between poverty and obesity. People living in poverty tend to maximise calories per dollar spent on food,8 and energy-dense foods rich in fats, refined starches and sugars represent the lowest cost options. Healthy diets based on lean meats, whole grains, and fresh vegetables and fruits are much more costly. Poverty in Indigenous communities is related to high unemployment and welfare dependency; living conditions are overcrowded, and community infrastructure is poor, with limited access to good quality foods.1 Many of these factors are compounded by remote living, although successful prevention of obesity in some outstation communities has been associated with greater physical activity, consumption of bush foods, and ownership of and access to traditional homelands.9
Are there any opportunities for practical intervention? Low birthweight, which is linked to an increased risk of central obesity and type 2 diabetes in adult life, is more common in Indigenous and other socially disadvantaged communities, and is linked to maternal smoking, overcrowded living conditions and mothers’ perceived stress.10 Furthermore, diabetes in pregnancy increases the risk of early onset obesity and diabetes in the offspring. This can be attenuated by improved control of gestational diabetes, and by the mother breastfeeding for at least 2–3 months.
Preventing and managing the complications of diabetes, such as cardiovascular risk factors, also involve lifestyle modification. Through changes in food supply, increased opportunities for physical activity, and health promotion, Indigenous communities were able to achieve amelioration of dyslipidaemia, improved insulin action (even in the absence of weight loss), and increased in red cell folate and reduced homocysteine levels.11 A large international trial has shown that fish and fish-oil supplements reduce coronary heart disease mortality.12
There seems little argument that improving the quality use of medicines (including through greater access) is one of the most cost-effective approaches to reducing the additional and preventable burden of chronic illness among Indigenous people.13,14 Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce mortality in an Aboriginal community with a high prevalence of end-stage kidney failure.15 Internationally, numerous trials have reported the effectiveness of statin therapy in reducing vascular mortality. Metformin improves glycaemic control in diabetes, without weight gain. Yet, the gaps between the evidence and actual practice, in both Indigenous communities and the broader community, remain unacceptably large, and are limiting gains for those at risk of diabetes and for those who already have the disease and related conditions.
The article by McDermott et al4 illustrates the value of systematic primary health care approaches to diabetes control, including electronic health information systems, screening, management protocols, recall systems, improved specialist access, quality improvement activities, and staff support and training (→ Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005). Such systems are integral to improving the quality and outcomes of clinical care. All three articles on diabetes in Indigenous people in this issue3,4,16 also address aspects of screening. Taken together, they support a critical role of coordinated health system approaches to diabetes identification and control. Simple point-of-care procedures, as developed by Marley et al16, could form the basis of cost-effective screening for diabetes (and other vascular risk factors) in high-risk populations, and may be able to accurately identify those who could benefit from more immediate pharmacological and non-pharmacological therapies (→ Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia).
